Mabtas 500 (Rituximab) 500mg/50ml

Mabtas 500 is a rituximab biosimilar injection used to treat certain autoimmune conditions and cancers. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance for proper use and handling.

Strength

500mg/50ml

Pack Size

1's

Storage

2-8ºC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mabtas 500 is commonly used for conditions like rheumatoid arthritis, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. It may also be prescribed for other autoimmune disorders when recommended by a doctor. Patients often ask, what is rituximab used for in these cases, and it targets specific immune cells to reduce inflammation and disease activity.

Side Effects

Mabtas 500 works by targeting CD20-positive B-cells, which can help reduce symptoms over time. Some users may experience effects like mild infusion reactions or flu-like symptoms shortly after administration. These effects are typically temporary and monitored during treatment.

Precautions & Warnings

Keep Mabtas 500 refrigerated between 2-8°C and protect from light. Avoid freezing or shaking the vial. Always check the solution for particles or discoloration before use. Discard any unused portion as directed by healthcare guidelines.

Avoid Interactions

Mabtas 500 may interact with other medications that affect the immune system, such as immunosuppressants or live vaccines. Discuss all current medications with your healthcare provider before starting treatment. Avoid alcohol or herbal supplements unless approved by a doctor.

Frequently Asked Questions

Mabtas 500 is used to treat autoimmune conditions like rheumatoid arthritis and certain cancers such as non-Hodgkin lymphoma.

Store Mabtas 500 between 2-8°C and protect from light. Do not freeze or shake the vial.

Mabtas 500 may be available through licensed online pharmacies with a valid prescription.

Common effects may include infusion reactions or flu-like symptoms, which are usually temporary.

Yes, Mabtas 500 is a biosimilar version of rituximab, designed to be highly similar to the reference product.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.